GSA Capital Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,332
| Closed | -$217K | – | 2108 |
|
|
2024
Q4 | $217K | Buy |
+11,332
| New | +$217K | 0.02% | 1374 |
|
|
2023
Q4 | – | Sell |
-10,844
| Closed | -$166K | – | 1972 |
|
|
2023
Q3 | $166K | Buy |
+10,844
| New | +$166K | 0.01% | 1321 |
|
|
2020
Q4 | – | Sell |
-1,288
| Closed | -$15K | – | 1633 |
|
|
2020
Q3 | $15K | Buy |
+1,288
| New | +$15K | ﹤0.01% | 1218 |
|